<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9304172</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Arenal Maíz, A</dc:author>
<dc:description xml:lang="en">The Multicenter Automatic Defibrillator Implantation Trial (MADIT) suggests that survival in patients with prior myocardial infarction, asymptomatic unsustained ventricular tachycardia and reduced left ventricular function was better among the patients who received implantable cardioverter defibrillator than that in the drug-treatment group. Nevertheless the absence of data about the efficacy and security of the conventional antiarrhythmic treatment weakness its result and clinical applicability.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1997 Jul </dc:date>
<dc:title xml:lang="es">Prevención de la muerte súbita postinfarto de miocardio: debe generalizarse la estrategia "MADIT"? Argumentos en contra.</dc:title>
<dc:title xml:lang="en">[Prevention of sudden death after myocardial infarction: should the "MADIT" strategy be generally applied? Arguments against].</dc:title>
<dc:publisher>Revista espanola de cardiologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
